British Columbia Discovery Fund
Suite 1630 – 609 Granville Street, Vancouver, BC, V7Y 1G5, Canada
Overview
British Columbia Discovery Fund (VCC) Inc. ("BC Discovery Fund," "BCDF" or the "Fund") is a diversified venture capital investment fund which allows investors to participate in the emerging technology industry in British Columbia. The Fund issues its shares under the Venture Capital Corporation (VCC) program, a BC government initiative to promote economic diversification and investment in small businesses, including technology ventures. In addition to enabling participation in innovative, local companies, BC Discovery Fund provides retail investors access to private venture capital investment opportunities, which are often only accessible to institutional shareholders and "angel" investors. Eligible individual investors in the Fund receive a tax credit equal to 30% of the amount invested, to a maximum of a $60,000 tax credit per annum. The tax credit on investments into the Fund during the first 60 days of the year can be carried back and applied against the prior year's taxes payable. To the extent that the amount of the tax credit exceeds an individual's British Columbia taxes otherwise payable, the individual is entitled to a refund of the difference. Shares in the Fund are eligible for RRSPs, RRIFs and RESPs. The tax credit is also available to B.C. corporations to reduce B.C. taxes payable.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- PHEMI
Led · Equity · Aug 2015
PHEMI provides privacy, security, governance and enterprise-grade management for big data, with a flagship product called PHEMI Central Big Data Warehouse that embeds privacy policies and enforces access privileges and data sharing agreements at the data level. The platform is designed to let organizations access and mine any variety of data at any volume while preserving privacy and supporting rigorous governance. PHEMI helps data-driven companies unlock and share data without compromising privacy, combining big-data scale and performance with features that support analytics and data science. The company announced a $10 million venture financing to expand commercialization through increased sales and marketing and outreach into emerging vertical markets. Proceeds will also be used to enhance R&D and extend solution offerings and sales reach through application and system integrator partners and data science expertise. PHEMI is based in Vancouver, British Columbia. PHEMI delivers a big-data warehouse platform that combines scale and performance with built-in privacy, security and governance to let organizations access and mine any variety of data. The company positions itself as an Organizational Ambassador for Privacy by Design (PbD) and emphasizes enabling discovery and innovation without compromising privacy. PHEMI’s initial market focus is healthcare and life sciences, and it plans to expand into public sector, insurance and financial services. The company intends to grow its commercial footprint by expanding sales, marketing and engineering and by extending solution offerings and sales reach through application and system integrator partners and data science expertise. Leadership includes serial entrepreneurs Dr. Paul Terry, Adam Lorant and John Seminerio alongside Chris Thompson and Alan Rabinowitz. PHEMI is based in Vancouver, British Columbia, and the recent financing is intended to accelerate its commercialization phase. Phemi Health Systems provides a patient care management platform and related data solutions for healthcare organizations. Led by Dr. Paul Terry, the company offers a suite of products that support collection, curation and analysis of rich healthcare datasets for population health management, clinical study engagement, evidence-based care, post-market surveillance, and quality and performance analytics. Its core products include PHEMI Clinical, a patient care management platform designed to improve clinic productivity and patient outcomes, and PHEMI Central, a Big Data–based data warehouse. On March 24, 2014 the company closed a $2.8M seed funding round. Backers included BDC Venture Capital, Yaletown Venture Partners and a number of strategic angel investors. The company intends to use the funds to commercialize its PHEMI Clinical and PHEMI Central platforms.
Team
No current team members are available.